Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002335997 | SCV002644625 | pathogenic | Hereditary cancer-predisposing syndrome | 2018-08-13 | criteria provided, single submitter | clinical testing | The c.51_61del11 pathogenic mutation, located in coding exon 1 of the MSH2 gene, results from a deletion of 11 nucleotides at nucleotide positions 51 to 61, causing a translational frameshift with a predicted alternate stop codon (p.G18Lfs*60). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |